Munich Re's Pricing Power Fades as Stock Tests Critical Support

Munich Re's stellar Q1 profit of €1.71B fails to lift shares as pricing softens; stock nears 52-week low of €437.50 with technical resistance and buyback underway.

The market is no longer rewarding Munich Re for what it earned yesterday. It is punishing it for what the reinsurance cycle will bring tomorrow, and the share price now sits just 3.36% above its 52-week low of €437.50 — a level that could determine whether the sell-off accelerates or stabilises.

The insurer posted a stellar first quarter, with net profit jumping to €1.714 billion from €1.094 billion a year earlier and the underwriting result rising to €2.676 billion. The full-year target of €6.3 billion remains intact, having been surpassed in 2024 with a record €6.12 billion. Yet the stock closed on Friday at €452.20, down 17.63% since the start of the year and 25.26% below the year's high of €605.00. The disconnect between operating performance and market reaction is stark — and it stems entirely from the outlook for pricing.

Reinsurers have already absorbed price cuts in the low double digits at the recent renewal rounds, and the trend accelerated in key markets. In Japan, April renewals saw declines in the mid-teen range, while US property catastrophe coverage fell 14%, up from 12% at the start of the year. As reinsurance capacity expands and insurance-linked securities gain traction, primary carriers are regaining negotiating leverage. Munich Re has responded by walking away from business it deems insufficiently priced; its written premium volume in the April renewal season dropped 18.5% to €2.0 billion. That discipline preserves underwriting quality but also signals that the peak of the cycle has passed.

Technically, the chart reinforces the bearish narrative. The stock trades 11.56% below its 50-day moving average of €511.33 and 14.90% below the 200-day average of €531.35, creating a thick resistance band that will cap any bounce. The 14-day relative strength index sits at 35.1 — weak but not yet in oversold territory. The 30-day loss of 13.77% and the 12-month decline of 21.30% underscore the depth of the correction.

Management is attempting to shore up confidence through a share buyback programme of up to €2.25 billion. The first tranche, capped at €900 million, began on 14 May and will run until 21 August 2026. In the latest reporting period the company bought back another 292,552 shares, bringing the total since launch to 763,544. Several board members also purchased stock near the year's low. These actions are efficient at depressed levels but have not yet provided a floor under the equity.

The next major catalyst is the European Central Bank meeting on 11 June. A rate cut would offer some relief on the investment income side, but it is the July renewal round that matters most for the share price. If Munich Re can hold pricing better than the market fears, some of the scepticism could recede. If conditions deteriorate further, the buyback will serve only as a partial counterweight to a softening cycle. With no corporate announcements due this week, attention will focus on whether the €437.50 low holds — a break below that level would mark a fresh 52-week trough and confirm the downtrend remains intact.